European Archives - Page 868 of 982 - European Medical Journal

Continue
EMJ
21 Mar 2016

Molecular Underpinning of Flexible Elastin Tissue Unveiled

MYSTERIOUS mechanisms of elastin tissue, a vital aspect of enabling our body to function, have finally been revealed through a novel combination of…
EMJ
21 Mar 2016

Seaweed Spawns Solutions to Stem Cell Storage and Treatment

PARAMEDICS and physicians will soon see a cost-effective solution to stem cell use through the pragmatic use of seaweed to treat wounds, particularly in…
EMJ
18 Mar 2016

STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy

STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy
EMJ
14 Mar 2016

Sneaking through Barrier Gaps: Gut Microbiota Imbalance Harms the Liver

March 14, 2016: The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions only. Prominent among the other organs…
EMJ
14 Mar 2016

New Human Papilloma Virus Vaccine Improves Cervical Cancer Protection

A VACCINE that protects against nine types of the human papilloma virus (HPV) has been developed by research scientists; this offers significantly…
EMJ
14 Mar 2016

Gold is a Girl’s Best Friend: A New Treatment for Ovarian Cancer

GOLD could form part of the treatment for ovarian cancer, as according to new research a gold-containing drug could improve the prognosis of patients…
EMJ
11 Mar 2016

Gut Profiling: New Biomarkers for Metabolic Diseases

March 11, 2016: For diagnosing or predicting metabolic diseases such as obesity, insulin resistance or type two diabetes (T2D), doctors commonly make use…
EMJ
11 Mar 2016

Treatment Advances and New Centres of Excellence Offer Lifeline to Patients with Inoperable Neuroendocrine Cancers

1 March 2016: A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope…
March 2016

EMJ Hepatology 4 [Suppl 3] 2016

Lysosomal acid lipase deficiency (LAL-D), historically known as Wolman’s disease or cholesteryl ester storage disease, is a severe, underdiagnosed…
11 Mar 2016

The Role of Sebelipase Alfa in Treating Lysosomal Acid Lipase Deficiency (LAL-D)

Lysosomal acid lipase deficiency (LAL-D), historically known as Wolman’s disease or cholesteryl ester storage disease, is a severe, underdiagnosed, and…